|【Grant Programs】||：||2017 Joint Usage and Joint Research Programs|
(A) Joint Usage
Up to 1,000,000 Japanese yens per successful proposal per fiscal
year will be supported for the following experiments.
A-1. Next-generation sequencing and microarray analyses, A-2. Epigenetic analysis, A-3. Proteome analysis, A-4. Genome editing of laboratory mice
(B) Joint Research
In general, up to 500,000 Japanese yens per proposal per fiscal year will be
supported to a successful research proposal. Those who need higher amount of the
budget can make a special request up to 1,000,000 Japanese yens per proposal per fiscal
year, by clarifying the special reason.
B-1. Division of Genome Medicine, B-2. Division of Epigenome Dynamics, B-3. Division of Protein Expression, B-4. Division of Disease Proteomics, B-5. Division of Cell Signaling, B-6. Division of Embryology, B-7. Division of Experimental Immunology, B-8. Division of Molecular Biology, B-9. Division of Inflammation Biology, B-10. Division of Enzyme Pathophysiology, B-11. Division of Molecular Neurobiology, B-12. Division of Molecular Immunology, B-13. Division of Molecular Medicine, B-14. Division of Immune Regulation, B-15. Division of Pathology and Metabolome Research for Infectious Disease and Host
Defense, B-16. Division of Molecular Endocrinology, B-17. Division of Diabetes Therapeutics and Research
A researcher affiliated with a university or a public research institute, or a researcher
approved by the Director of the Institute of Advanced Medical Sciences. The Institute of Advanced Medical Sciences does not discriminate on the
basis of nationality, race, religion, disability, gender, marital status, sexual orientation,
age, or any other illegal or unfair basis.
Approved joint usage and/or joint research should be
performed between 1st April 2017 and 31st March 2018.